Pilot Trial of a Synbiotic in HIV+ Patients

Completed · Not applicable · Has a placebo group

Conditions studied: HIV Infection

In brief

The goal of this study is to test the hypothesis that daily ingestion of a 'synbiotic' for 4 weeks will improve intestinal function, ease immune system overactivation, and increase blood CD4 count in HIV-infected individuals. A 'Synbiotic' is a mixture of probiotic bacteria and dietary fiber.

Key facts

Study ID

NCT00688311

Run by

University of California, Davis

People needed

34

Starts

2008-05-01

Expected to finish

2009-11-01

Last updated by the study team

2009-11-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• HIV seropositive
• Adult Female
• Currently taking antiretroviral medication

You may not qualify if…

• AIDS-defining conditions
• Current use of oral antibiotics
• Inflammatory bowel disease or other known GI pathology

Where it is running

• CARES Clinic — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.